[go: up one dir, main page]

AU2001279693A1 - Anthelmintic agents for preventing parasitic infections in humans and animals iii - Google Patents

Anthelmintic agents for preventing parasitic infections in humans and animals iii

Info

Publication number
AU2001279693A1
AU2001279693A1 AU2001279693A AU7969301A AU2001279693A1 AU 2001279693 A1 AU2001279693 A1 AU 2001279693A1 AU 2001279693 A AU2001279693 A AU 2001279693A AU 7969301 A AU7969301 A AU 7969301A AU 2001279693 A1 AU2001279693 A1 AU 2001279693A1
Authority
AU
Australia
Prior art keywords
humans
parasitic infections
anthelmintic agents
preventing parasitic
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279693A
Other languages
English (en)
Inventor
Dr. Achim Harder
Bernd-Wieland Kruger
Heinz Mehlhorn
Jurgen Schmidt
Georg Von Samson-Himmelstjerna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001279693A1 publication Critical patent/AU2001279693A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001279693A 2000-07-06 2001-06-26 Anthelmintic agents for preventing parasitic infections in humans and animals iii Abandoned AU2001279693A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10032877A DE10032877A1 (de) 2000-07-06 2000-07-06 Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier III
DE10032877 2000-07-06
PCT/EP2001/007294 WO2002002088A2 (de) 2000-07-06 2001-06-26 Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii

Publications (1)

Publication Number Publication Date
AU2001279693A1 true AU2001279693A1 (en) 2002-01-14

Family

ID=7648011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279693A Abandoned AU2001279693A1 (en) 2000-07-06 2001-06-26 Anthelmintic agents for preventing parasitic infections in humans and animals iii

Country Status (16)

Country Link
US (1) US20030186980A1 (de)
EP (1) EP1301188B1 (de)
JP (1) JP2004501960A (de)
KR (1) KR20030009549A (de)
CN (1) CN1440289A (de)
AT (1) ATE279195T1 (de)
AU (1) AU2001279693A1 (de)
BR (1) BR0112195A (de)
CA (1) CA2414678A1 (de)
DE (2) DE10032877A1 (de)
DK (1) DK1301188T3 (de)
ES (1) ES2230348T3 (de)
HU (1) HUP0300800A3 (de)
PL (1) PL359649A1 (de)
WO (1) WO2002002088A2 (de)
ZA (1) ZA200300056B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012104865A1 (en) * 2011-01-28 2012-08-09 Director General, Defence Research & Development Organisation (Drdo) N, n- dialkyl -morpholin- 4 - carboxamide compounds as insect repelling agents and a process for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2050522A5 (en) * 1969-06-17 1971-04-02 Aries Robert Pesticidal carbamoyl morpholines
US5371239A (en) * 1989-12-22 1994-12-06 American Cyanamid Company Methods and compositions for protecting animals against attack and infestation by helminth, acarid and arthropod endo- and ectoparasites
DE4018070A1 (de) * 1990-06-06 1991-12-12 Bayer Ag Morpholinoharnstoff-derivate

Also Published As

Publication number Publication date
JP2004501960A (ja) 2004-01-22
HUP0300800A3 (en) 2005-10-28
CA2414678A1 (en) 2002-01-03
BR0112195A (pt) 2003-07-01
DK1301188T3 (da) 2005-01-10
HUP0300800A2 (hu) 2003-08-28
ATE279195T1 (de) 2004-10-15
PL359649A1 (en) 2004-08-23
CN1440289A (zh) 2003-09-03
WO2002002088A2 (de) 2002-01-10
EP1301188B1 (de) 2004-10-13
ES2230348T3 (es) 2005-05-01
US20030186980A1 (en) 2003-10-02
DE10032877A1 (de) 2002-02-07
KR20030009549A (ko) 2003-01-29
EP1301188A2 (de) 2003-04-16
DE50104130D1 (de) 2004-11-18
WO2002002088A3 (de) 2002-05-10
ZA200300056B (en) 2004-01-21

Similar Documents

Publication Publication Date Title
EP1478322A4 (de) Beta-2'-OR 3'-HALONUCLEOSIDE
WO2001076370A3 (en) Anthelmintic combinations
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE511352T1 (de) Antimikrobielle zusammensetzungen
AU2005099A (en) Methods and compositions for the treatment and prevention of (staphylococcus aureus) infections
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
WO2004085682A3 (de) Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza
WO2005054234A3 (en) Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
ATE229269T1 (de) Ektoparasitizide mittel
WO2003009859A1 (en) Immunotherapy for humans
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
WO2002072581A3 (en) Pyrazolopyriadine derivatives
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
TR199901374T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
AU2001279693A1 (en) Anthelmintic agents for preventing parasitic infections in humans and animals iii
AU6908801A (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals
WO2002002087A3 (de) Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor
WO2000041473A3 (de) Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen
WO2000041526A3 (en) Use of s-triazines for treating apicomplexan parasitic infections
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
ATE315038T1 (de) Antibakterielle mittel
WO2002002089A3 (de) Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iv
DE60233647D1 (de) Reduziertes vitamin b2 enthaltende arzneimittel

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application